Company Filing History:
Years Active: 2015-2020
Title: The Innovative Contributions of Inventor Nicola Sardone
Introduction
Nicola Sardone, based in Milan, Italy, is a prominent inventor known for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has made noteworthy advancements in drug formulation and delivery.
Latest Patents
Among Nicola's latest patents is the invention of novel crystalline forms of lenvatinib, a compound with crucial applications in treating various types of cancer. His patent, titled "Crystal forms of lenvatinib," provides innovative crystalline forms of 4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate and outlines methods for their preparation.
Additionally, he has developed solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate), as detailed in his patent titled "Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same." This invention includes a variety of solid forms selected from amorphous to crystalline anhydrous states, as well as several solid solvates such as acetonitrile, toluene, and dichloromethane/heptane, which can serve as intermediates in pharmaceutical applications.
Career Highlights
Nicola Sardone is currently associated with Indena S.p.A., a renowned company that specializes in producing plant-derived active ingredients for the pharmaceutical and health industries. His tenure at Indena has been marked by innovation and dedication, leveraging his expertise in medicinal chemistry.
Collaborations
Throughout his career, Nicola has collaborated with several esteemed colleagues, including Andrea Gambini and Daniele Ciceri. These partnerships have enhanced his research capabilities, contributing to the successful development of patented pharmaceutical formulations.
Conclusion
Nicola Sardone's inventive work continues to impact the pharmaceutical sector positively. With a focus on creating novel forms of important compounds, he demonstrates a commitment to advancing drug delivery systems, thereby supporting therapeutic efficacy and patient wellness. His contributions are a testament to the importance of innovation in the field of pharmaceuticals.